Our growth story has only just begun. We endeavour to mitigate risk for investors and encourage transparency in all our dealings
Investor Presentation | Natco Pharma
This presentation contains forward-looking statements and information that involve risks, uncertainties and assumptions. Forward-looking statements are all statements that concern plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical fact, including, but not limited to, those that are identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects” and similar expressions. Risks and uncertainties that could affect us include, without limitation:
General economic and business conditions in India
The ability to successfully implement our strategy, our research and development efforts, growth and expansion plans and technological changes
Changes in the value of the Rupee and other currency changes
Changes in the Indian and international interest rates
Allocations of funds by the Government
Changes in laws and regulations that apply to our customers, suppliers, and the pharmaceutical industry
Increasing competition in and the conditions of our customers, suppliers and the pharmaceutical industry
Changes in political conditions in India
Should one or more of such risks and uncertainties materialize, or should any underlying assumption prove incorrect, actual outcomes may vary materially from those indicated in the applicable forward-looking statements. Any forward looking statement or information contained in this presentation speaks only as of the date of the statement. We are not required to update any such statement or information to either reflect events or circumstances that occur after the date the statement or information is made or to account for unanticipated events.
NATCO Pharma Q3 FY 2022-23 Investor Presentation
NATCO Pharma Q2 FY 2022-23 Investor Presentation
NATCO Pharma Q1 FY 2022-23 Investor Presentation
NATCO Pharma Q4 FY 2021-22 Investor Presentation
NATCO Pharma Q3 FY 2021-22 Investor Presentation
NATCO Pharma Q2 FY 2021-22 Investor Presentation
NATCO Pharma Q1 FY 2021-22 Investor Presentation
NATCO Pharma Q4 FY 2020-21 Investor Presentation
NATCO Pharma Q3 FY 2020-21 Investor Presentation
NATCO Pharma Q2 FY 2020-21 Investor Presentation
NATCO Pharma Q1 FY 2020-21 Investor Presentation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy